跳至主要内容
临床试验/NCT01491165
NCT01491165Unknown2 期

Safety and Efficacy of Umbilical Cord Mesenchyma Stem Cell Transplantation in Liver Cirrhosis Patients

General Hospital of Chinese Armed Police Forces1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2011年12月1日最近更新:
适应症

试验速览

阶段
2 期
发起方
入组人数
75
试验地点
1
主要终点
liver volume calculated by MRI

研究概览

简要总结

Mainstream of current treatment of liver cirrhosis is liver transplantation, but there are high cost, risk and immune rejection and other issues. Umbilical cord mesenchyma stem cell with self-and directed differentiation capacity can effectively rescue experimental liver failure and contribute to liver regeneration, which suggests the feasibility of stem cell transplantation therapy. In this study, the safety and efficacy of umbilical cord mesenchyma stem cell transplantation through interventional procedures in patients liver cirrhosis will be evaluated.

详细描述

This study included three research centers, each center were carried out 25 cases of liver cirrhosis in patients with stem cell transplantation. All the selection and exclusion criteria are same, data summary and analysis will be complete by the epidemiological commissioner.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of liver cirrhosis;
  • Without hepatic encephalopathy;
  • No ascites or have easily dissipated ascites;
  • Value of bilirubin is less than 100;
  • Value of albumin is greater than 16 g / L;
  • Prothrombin time is less than 21 seconds;

排除标准

  • Severe cardiovascular disease, and immunocompromised patients;
  • Patients with localized lesions affecting graft infection;
  • Coagulation disorders;
  • Liver nodules more than 2cm or Liver cancer

结局指标

主要结局

liver volume calculated by MRI

时间窗: 3 days before transplantation, 6 and 12 months after transplantation

Instrument:universal 1.5 Tesla superconducting MRI instrument. Slice thickness :2mm.

次要结局

  • liver biopsy(whinin 7 days before transplantation, 6 and 12 months after transplantation)
  • liver enzyme fiber spectrum(whinin 7 days before transplantation, 1,3,6 and 12 months after transplantation)
  • portal vein and splenic vein measure(whinin 7 days before transplantation, 1,3,6 and 12 months after transplantation)
  • blood biochemistry(whinin 7 days before transplantation, 1,3,6 and 12 months after transplantation)
  • coagulation(whinin 7 days before transplantation, 1,3,6 and 12 months after transplantation)
  • blood test(whinin 7 days before transplantation, 1,3,6 and 12 months after transplantation)
  • gastroscopy(whinin 7 days before transplantation, 6 and 12 months after transplantation)

研究者

发起方
General Hospital of Chinese Armed Police Forces
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Safety and Efficacy of Stem Cell Transplantation for... | 临床试验